Page last updated: 2024-11-06

triethylenemelamine and Glioma

triethylenemelamine has been researched along with Glioma in 1 studies

Triethylenemelamine: Toxic alkylating agent used in industry; also as antineoplastic and research tool to produce chromosome aberrations and cancers.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crue, BL1
Todd, EM1
Lockwood, RW1

Other Studies

1 other study available for triethylenemelamine and Glioma

ArticleYear
II. Medulloblastoma. Therapy with triethylene melamine and cobalt 60 irradiation.
    Bulletin of the Los Angeles neurological societies, 1967, Volume: 32, Issue:3

    Topics: Cerebellar Neoplasms; Cerebellum; Child; Cobalt Isotopes; Culture Techniques; Ependymoma; Glioma; Hu

1967